Pattern of Intermediate Uveitis in an Egyptian Cohort

REFERENCES

• Kempen JH, Gewaily DY, Newcomb CW, et al. Remission of intermediate uveitis: Incidence and predictive factors. Am J Ophthalmol. Apr 2016;164:110–117. doi:10.1016/j.ajo.2015.12.034.
   PubMed Web of Science ®Google Scholar
• De Boer J, Berendschot TT, Van Der Does P, et al. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. Apr 2006;141(4):616–621.
   PubMed Web of Science ®Google Scholar
• Vitale AT, Zierhut M, Foster CS. Intermediate uveitis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders Company; 2001:844–857.
   Google Scholar
• Nussenblatt RB, Whitcup SM, Palestine AG. Intermediate uveitis. In: Craven L, ed. Uveitis, Fundamentals, and Clinical Practice. St Louis: Mosby; 1996:279–288.
   Google Scholar
• Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13:461–465.
   PubMed Web of Science ®Google Scholar
• Pruett RC, Brockhurst J, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol. 1974;77:448–453.
   PubMed Web of Science ®Google Scholar
• Smith RE, Godfrey WA, Kimura SJ. Complications of chronic cyclitis. Am J Ophthalmol. 1976;82:277–282.
   PubMed Web of Science ®Google Scholar
• Malinowski SM, Pulido JS, Folk JC. Long term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100:818–824.
   PubMed Web of Science ®Google Scholar
• Donaldson MJ, Pulido JS, Herman DC, et al. Pars planitis: A 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144:812–817.
   PubMed Web of Science ®Google Scholar
• Prieto JF, Dios E, Gutierrez JM, et al. Pars planitis: Epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9:93–102.
   PubMed Web of Science ®Google Scholar
• Deane JS, Rosenthal AR. Course and complications of intermediate uveitis. Acta Ophthalmol Scand. 1997;75:82–84.
   PubMedGoogle Scholar
• Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–125.
   PubMedGoogle Scholar
• Malla OK, Karki DB, Byanju RN, et al. Intermediate uveitis: A hospital based study. Kathmandu Univ Med J (KUMJ). 2004;2(4):354–359.
   PubMedGoogle Scholar
• Arellanes-Gracia L, Navarro-Lopez L, Recillas-Gispert C. Pars planitis in the Mexican Mestizo population: Ocular findings, treatment, and visual outcome. Ocul Immunol Inflamm. 2003;11:53–60.
   PubMed Web of Science ®Google Scholar
• Hamade IH, Al Shamsi HN, Al Dhibi H, et al. Uveitis survey in children. Br J Ophthalmol. 2009;93(5):569–572.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Hmidi K, Attia S, et al. Clinical characteristics of intermediate uveitis in Tunisian patients. Int Ophthalmol. 2010;30:531–537.
   PubMedGoogle Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria” . Ann Neurol. 2005;58:840–846.
   PubMed Web of Science ®Google Scholar
• Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46:195–208.
   PubMed Web of Science ®Google Scholar
• Kraut JA, McCabe CP. The problem of low vision. Definition and common problems. Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol. 5. Philadelphia: WB Saunders Company. 1994; 3664–3666.
   Google Scholar
• Lange C, Feltgen N, Junker B, et al. Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137–142.
   PubMed Web of Science ®Google Scholar
• Kwon YH, Kim CS, Zimmerman MB, et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132(1):47–56.
   PubMed Web of Science ®Google Scholar
• Capone A, Aaberg TM. Intermediate uveitis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol. 1. chap 26. Philadelphia: W.B. Saunders; 1994
   Google Scholar
• Chan CKM, Wu ZHY, Luk FOJ, et al. Clinical characteristics of intermediate uveitis in Chinese patients. Ocul Immunol Inflamm. 2013;21:71–76.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: Fundamentals and Clinical Practice. 3rd ed. St. Louis: CV Mosby; 2004:291–300.
   Google Scholar
• Ortega-Lorrocea G, Arrllanes-Garcia L. Pars planitis: Epidemiology and clinical outcome in a large community hospital in Mexico City. Int Ophthalmol. 1995;19:117–120.
   PubMed Web of Science ®Google Scholar
• Park DW, Folk JC, Whitcup SM, et al. Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation. Arch Ophthalmol. 1998;116:1025–1029.
   PubMedGoogle Scholar
• Vidovic Valentincic N, Kraut A, Hawlina M, et al. Intermediate uveitis: Long-term course and visual outcome. Br J Ophthalmol. Dec 9, 2008;93(4):477–80. doi:10.1136/bjo.2008.149039.
   PubMed Web of Science ®Google Scholar
• Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57.
   PubMed Web of Science ®Google Scholar
• Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58:21–27.
   PubMed Web of Science ®Google Scholar
• Grajewski RS, Caramoy A, Frank KF, et al. Spectrum of uveitis in A German Tertiary center: Review of 474 consecutive patients. Ocul Immunol Inflamm. 2015;23(4):346-352. doi:10.3109/09273948.2014.1002567.
   PubMed Web of Science ®Google Scholar
• Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–948.
   PubMed Web of Science ®Google Scholar
• Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–183.
   PubMedGoogle Scholar
• Boskovich SA, Lowder CY, Meisler DM, et al. Systemic diseases associated with intermediate uveitis. Clevel Clin J Med 1993;60:460–465.
   PubMed Web of Science ®Google Scholar
• Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76:137–141.
   PubMed Web of Science ®Google Scholar
• Graham EM, Edelsten C. Intermediate uveitis and sarcoidosis. Dev Ophthalmol. 1992;23:106–110.
   PubMedGoogle Scholar
• Shakarchi FI. Ocular tuberculosis: Current perspectives. Clin Ophthalmol Auckl NZ. 2015;9:2223–2227.
   PubMed Web of Science ®Google Scholar
• Ness T, Boehringer D, Heinzelmann S. Intermediate uveitis: Pattern of etiology, complications, treatment and outcome in a tertiary academic center. Orphanet J Rare Dis. 2017;12:81.
   PubMed Web of Science ®Google Scholar
• Zein G, Berta A, Foster CS. Multiple sclerosis associated uveitis. Ocul Immunol Inflamm. 2004;12:137–142.
   PubMed Web of Science ®Google Scholar
• Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: Clinical features and class II HLA associations. Ophthalmology. 1999;106(3):594–599.
   PubMed Web of Science ®Google Scholar
• Merayo-Lioves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300–304.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Harvlikova K, Power WJ, et al. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375–383.
   PubMed Web of Science ®Google Scholar
• Giles CL. Pediatric intermediate uveitis. J Pediatr Ophthalmol Strabismus. 1989;26:136–139.
   PubMedGoogle Scholar
• Bonfioli AA, Damico FM, Curi AL, et al. Intermediate uveitis. Semin Ophthalmol. 2005;20:147–154.
   PubMedGoogle Scholar
• Bajwa A, Osmanzada D, Osmanzada S, et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol Auckl NZ. 2015;9:889–901.
   PubMed Web of Science ®Google Scholar
• Lauer AK, Smith JR, Robertson JE, et al. Vitreous hemorrhage is a common complication of pediatric pars planitis. Ophthalmology. 2002;109(1):95–98.
   PubMed Web of Science ®Google Scholar
• Kaplan HJ. Intermediate uveitis (pars planitis, chronic cyclitis). A four-step approach to treatment. In: Saari KM, ed. Uveitis Update. Amsterdam: Excerpta Medica; 1984:169–172.
   Google Scholar
• Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55–64.
   PubMed Web of Science ®Google Scholar
• Riordan-Eva P, Lightman S. Orbital floor steroid injections in the treatment of uveitis. Eye. 1994;8:66–69.
   PubMed Web of Science ®Google Scholar
• Lai WW, Pulido JS. Intermediate uveitis. Ophthalmol Clin North Am. 2002;15:309–317.
   PubMedGoogle Scholar
• Belfort R Jr, de Abreu MT, Petrilli AM, et al. Cytotoxic drugs in intermediate uveitis. Dev Ophthalmol. 1992;23:171–176. ( Review)
   PubMedGoogle Scholar
• Jones NP. The manchester uveitis clinic: The first 3000 patients, 2: Uveitis manifestations, complications, medical and surgical management. Ocul Immunol Inflamm. 2015;23:127–134.
   PubMed Web of Science ®Google Scholar